Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume 9, Issue 10, Pages 1901858
Publisher
Wiley
Online
2020-04-29
DOI
10.1002/adhm.201901858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of Triple-Negative Breast Cancer Preclinical Models Provides Functional Evidence of Metastatic Progression
- (2019) Juan J. Arroyo-Crespo et al. INTERNATIONAL JOURNAL OF CANCER
- Boosting Interleukin‐12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR‐Tagged Nanogold
- (2019) Anna Maria Gasparri et al. Small
- Recent progress in drug delivery
- (2019) Chong Li et al. Acta Pharmaceutica Sinica B
- Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
- (2019) Bradley N. Mills et al. Cell Reports
- Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice
- (2019) Mintai P. Hwang et al. JOURNAL OF CONTROLLED RELEASE
- Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi-Based Immunochemotherapy of Intracranial Glioblastoma Treatment
- (2018) Chenmeng Qiao et al. ADVANCED MATERIALS
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immunochemotherapy mediated by thermosponge nanoparticles for synergistic anti-tumor effects
- (2018) Yongdan Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of Doxorubicin and Interferon-gamma by Thermosensitive Nanoparticles for Cancer Immunochemotherapy
- (2018) Yijia Yin et al. MOLECULAR PHARMACEUTICS
- A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
- (2018) Tingting Wang et al. Nature Communications
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up
- (2018) Sylvia Adams et al. JAMA Oncology
- Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
- (2017) Huige Peng et al. NANO LETTERS
- Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
- (2017) Qingle Song et al. NANO LETTERS
- Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy
- (2017) Sung Duk Jo et al. Nano Today
- Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer
- (2017) Xiaoxiao Liu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Microneedle-Assisted, DC-Targeted Codelivery of pTRP-2 and Adjuvant of Paclitaxel for Transcutaneous Immunotherapy
- (2017) Jiaojiao Xu et al. Small
- Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
- (2017) Oh Youn Kim et al. Nature Communications
- Intratumoral CD8 + T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity
- (2017) Brendan L. Horton et al. Cancer Immunology Research
- Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
- (2017) Jane Cullis et al. Cancer Immunology Research
- Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
- (2016) Xiao Zhao et al. BIOMATERIALS
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
- (2016) Yichao Chen et al. Nature Communications
- Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic Delivery
- (2015) Chun-Yang Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent progress in biomedical applications of Pluronic (PF127): Pharmaceutical perspectives
- (2015) Muhammad Sajid Hamid Akash et al. JOURNAL OF CONTROLLED RELEASE
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Real-Time Detection of CTL Function Reveals Distinct Patterns of Caspase Activation Mediated by Fas versus Granzyme B
- (2014) Jinzhu Li et al. JOURNAL OF IMMUNOLOGY
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
- (2014) Gunter von Minckwitz et al. LANCET ONCOLOGY
- A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins
- (2014) Won Il Choi et al. NANO LETTERS
- Acidic pH-Responsive siRNA Conjugate for Reversible Carrier Stability and Accelerated Endosomal Escape with Reduced IFNα-Associated Immune Response
- (2013) Hiroyasu Takemoto et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer
- (2013) Rupal Ramakrishnan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Improved Efficacy of Dendritic Cell-Based Immunotherapy by Cutaneous Laser Illumination
- (2012) X. Chen et al. CLINICAL CANCER RESEARCH
- Magnetic nanoparticles (MNPs) covalently coated by PEO–PPO–PEO block copolymer for drug delivery
- (2012) Ning Wang et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- PLGA-based nanoparticles: An overview of biomedical applications
- (2012) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Macrophage plasticity and polarization in tissue repair and remodelling
- (2012) Alberto Mantovani et al. JOURNAL OF PATHOLOGY
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer
- (2011) Qiushan He et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Selective Impairment of CD4+CD25+Foxp3+Regulatory T cells by paclitaxel is explained by Bcl-2/Bax mediated apoptosis
- (2010) Nan Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Surface grafting thermoresponsive PEO-PPO-PEO chains
- (2010) Ram Malal et al. Journal of Tissue Engineering and Regenerative Medicine
- In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems
- (2010) Boitumelo Semete et al. Nanomedicine-Nanotechnology Biology and Medicine
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started